Βy Prof. Daniele Regge [Chief of the Radiology Unit, Candiolo Cancer Institute, Torino-Italy] and Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] The clinical validation study was designed to assess the diagnostic performance of artificial intelligence (AI)...
Newsletter #8
ProCAncer-I: From Research to Market Impact
Βy Paris Ziogkas, the Co-Founder | CEO at Advantis Medical Imaging As the ProCAncer-I project reaches its conclusion, we celebrate a collective achievement that stands as a beacon of what European collaboration can deliver at the forefront of medical AI....
MRI quality assessment for Artificial Intelligence applications: Insights from the ProCancer I project
Βy Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] Acquisition of high-quality magnetic resonance imaging (MRI) examinations is essential for the accurate detection and characterization of prostate cancer, as poor image quality can obscure lesions and...
Researchers are using artificial intelligence to improve how prostate cancer is detected and diagnosed through MRI scans
Βy Nickolas Papanikolaou [Principal Investigator in Oncologic Imaging at the Fundação Champalimaud] Researchers are using artificial intelligence to improve how prostate cancer is detected and diagnosed through MRI scans. In one part of the project, the goal was to...
Newsletter #8 Contents
Highlights

Artificial intelligence can help in the non-invasive diagnosis of prostate cancer
Aug 18, 2025
An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging...

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Aug 12, 2025
Prostate cancer is the second most commonly diagnosed cancer in men. Conventional screening relies on prostate specific antigen (PSA) levels in the blood, which can indicate prostate abnormalities but lacks specificity. Clinical examination and ultrasound also have...

ProCAncer-I project vision and results
Jul 2, 2025
The ProCAncer-I project aims to revolutionize prostate cancer diagnosis and treatment through the power of artificial intelligence and advanced imaging. By creating a large, federated database of prostate MRI scans and clinical data, the project enables the...

AI Improves prostate cancer (PCa) detection: Clinical Validation of AI models
Jun 24, 2025
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...